Steven Frank

Insider Reports History

Location
20374 Seneca Meadows Parkway, Germantown, MD
Signature
/s/ Alane P. Barnes, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Steven Frank:

Stock Role Class Num Shares Value Price $ Report Date Ownership
PRECIGEN, INC. Director Common Stock 1.14M $1.98M $1.74 Mar 14, 2025 Direct
BIOCRYST PHARMACEUTICALS INC Director Common Stock 16.1K $133K $8.31 Aug 29, 2025 Direct
PRECIGEN, INC. Director Restricted Stock Units 0 $0 $1.74 Mar 14, 2025 Direct
PRECIGEN, INC. Director Option to Purchase Common Stock (Right to Buy) 83.5K Mar 13, 2025 Direct
BIOCRYST PHARMACEUTICALS INC Director Automatic Stock Option Grant 27.2K Jun 12, 2025 Direct

Insider Reports Filed by Steven Frank

Symbol Company Period Transactions Value $ Form Type Date Filed Role
BCRX BIOCRYST PHARMACEUTICALS INC Aug 29, 2025 1 $11.2K 4 Sep 3, 2025 Director
BCRX BIOCRYST PHARMACEUTICALS INC Jun 12, 2025 2 $0 4 Jun 16, 2025 Director
BCRX BIOCRYST PHARMACEUTICALS INC May 30, 2025 1 $3.58K 4 Jun 3, 2025 Director
BCRX BIOCRYST PHARMACEUTICALS INC May 2, 2025 2 $0 4 May 6, 2025 Director
BCRX BIOCRYST PHARMACEUTICALS INC May 2, 2025 0 $0 3 May 6, 2025 Director
PGEN PRECIGEN, INC. Mar 13, 2025 5 $50K 4 Mar 17, 2025 Director
PGEN PRECIGEN, INC. Mar 14, 2024 3 $50K 4 Mar 18, 2024 Director
PGEN PRECIGEN, INC. Mar 9, 2024 2 $0 4 Mar 12, 2024 Director
PGEN PRECIGEN, INC. Aug 14, 2023 1 $688K 4 Aug 15, 2023 Director
PGEN PRECIGEN, INC. Mar 9, 2023 3 $50K 4 Mar 13, 2023 Director
PGEN PRECIGEN, INC. Feb 22, 2023 2 $0 4 Feb 24, 2023 Director
PGEN PRECIGEN, INC. Mar 25, 2022 2 $0 4 Mar 29, 2022 Director
PGEN PRECIGEN, INC. Feb 22, 2022 3 $50K 4 Feb 24, 2022 Director